4,750,000 Shares Lion Biotechnologies, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • May 4th, 2015 • Lion Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
Introductory. The stockholders of Lion Biotechnologies, Inc., a Nevada corporation (the “Company”), named in Schedule A (the “Selling Stockholders”) propose to sell to the several underwriters named in Schedule B (the “Underwriters”) an aggregate of 4,750,000 shares of the Company’s common stock, par value $0.000041666 per share (the “Shares”), with each Selling Stockholder selling up to the amount set forth opposite such Selling Stockholder’s name in Schedule A, as provided in Section 2. The 4,750,000 Shares to be sold by the Selling Stockholders are called the “Offered Shares.” Jefferies LLC (“Jefferies”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule B, the term “Representative” as used herein shall mean you, as Underwriter, and the term “Underwriters” shall mean either the singular or the plur
